Yahoo

CBAK Energy Technology Stock And 2 Top Penny Stocks To Watch

Trade ACIU on Coinbase

Global inflation is expected to stay above central bank targets into 2027, and the OECD sees more rate hikes as likely. Cash sitting on the sidelines could lose real buying power if that happens. Investors looking for stocks under US$5 with stronger balance sheets, limited dilution, and meaningful insider ownership are hunting harder. This piece highlights three such penny stocks that have already moved up over the past year.

These three examples are only a starter set, and the full screen surfaced 6 more penny stocks with similarly tight capital discipline, cleaner balance sheets, and strong insider alignment that are not covered below. To go straight to the full list and pressure test your own ideas, head into the Elite Penny Stocks screener to identify, analyze, and prioritize your highest conviction elite penny candidates.

CBAK Energy Technology (CBAT)

CBAK Energy Technology manufactures lithium ion and sodium ion batteries and integrated battery systems for electric vehicles and energy storage, tying it squarely to the Elite Penny Stocks focus on real assets in high growth EV and ESS niches. The CBAK segment generated about US$123 million and Hitrans about US$107 million in revenue, with a market value near US$103 million.

CBAK Energy Technology fits the screener theme through its EV and energy storage battery lines, combining a low P/S multiple with a forecast 38.1% revenue growth profile in a market that remains focused on cell supply. The key question is how one unresolved funding pressure interacts with that growth plan.

That funding question is the real hinge for CBAK Energy Technology, so pull up the 3 key rewards and 2 important warning signs to see what might accelerate or derail the current plan.

NasdaqCM:CBAT Earnings & Revenue Growth as at Sep 2026
NasdaqCM:CBAT Earnings & Revenue Growth as at Sep 2026

Guerrilla RF (GUER)

Guerrilla RF is a fabless semiconductor company that designs and sells RF chips such as power amplifiers and ultra low noise amplifiers used in 5G and other wireless infrastructure. It generates about $27 million from high performance MMIC products, with a market cap near $44 million.

Guerrilla RF fits into the Elite Penny Stocks theme through its RF power and front end chips for 5G and wireless infrastructure. It has a P/S of 1.6x, forecast revenue growth around 27.3% a year, and an earnings ramp that analysts expect could turn profitable within three years. What matters next is how one unseen pressure shapes that path.

That unseen pressure is the real swing factor, so pull up the 3 key rewards and 1 important warning sign to see what could accelerate Guerrilla RF or quietly cap its upside.

OTCPK:GUER Earnings & Revenue Growth as at Sep 2026
OTCPK:GUER Earnings & Revenue Growth as at Sep 2026

AC Immune (ACIU)

AC Immune focuses on antibodies and diagnostics for neurodegenerative diseases such as Alzheimer's, fitting the Elite Penny Stocks theme through growth forecasts tied to these high need indications. The business generated about CHF 18 million from discovering and developing therapeutic and diagnostic products, with a market cap near US$264 million.

AC Immune appears in the screener because of earnings and revenue growth forecasts and a market value around US$264 million that is described as well below some fair value estimates. Clinical progress and a path toward profitability matter, depending on how one unseen pressure around funding and execution plays out.

That funding and execution hinge makes the analyst forecasts for AC Immune a useful way to see whether AC Immune's potential trajectory matches your risk appetite before the story shifts.

NasdaqGM:ACIU Earnings & Revenue Growth as at Sep 2026
NasdaqGM:ACIU Earnings & Revenue Growth as at Sep 2026

Seeking Alternatives Before The Crowd Moves

Fresh ideas move first. Prices follow. Scan these under the radar picks while the momentum is building, not after the breakout gets caught by everyone else.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: